Annals ofNephrology

Volume: 6 - Number: 59 - June 15, 2008

Outstanding

Relief of Nocturnal Enuresis by Desmopressin Is Kidney and Vasopressin Type 2 Receptor Independent

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase Therapy in Patients with Fabry Disease

Role of Microsomal Prostaglandin E Synthase 1 in the Kidney

Basic Immunology and Pathology

Overexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in Rats

Neutralization of Macrophage-Stimulating Protein Ameliorates Renal Injury in Anti–Thy 1 Glomerulonephritis

Cell and Transport Physiology

Distal Renal Tubular Acidosis in Mice Lacking the AE1 (Band3) Cl–/HCO3– Exchanger (slc4a1)

Sodium-Hydrogen Exchanger Regulatory Factor-1 Interacts with Mouse Urate Transporter 1 to Regulate Renal Proximal Tubule Uric Acid Transport

Acidosis-Sensing Glutamine Pump SNAT2 Determines Amino Acid Levels and Mammalian Target of Rapamycin Signalling to Protein Synthesis in L6 Muscle Cells

Canonical Transient Receptor Potential 1 Channel Is Involved in Contractile Function of Glomerular Mesangial Cells

Oxidative Stress Causes Renal Dopamine D1 Receptor Dysfunction and Hypertension via Mechanisms That Involve Nuclear Factor-B and Protein Kinase C

Clinical Nephrology

Relief of Nocturnal Enuresis by Desmopressin Is Kidney and Vasopressin Type 2 Receptor Independent

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase Therapy in Patients with Fabry Disease

Urinary Angiotensinogen as a Marker of Intrarenal Angiotensin II Activity Associated with Deterioration of Renal Function in Patients with Chronic Kidney Disease

Frontiers in nephrology

Role of Primary Cilia in the Pathogenesis of Polycystic Kidney Disease

Wnt Signaling in Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease: Time for a Change?

Genetics and development

Pax Transactivation-Domain Interacting Protein Is Required for Urine Concentration and Osmotolerance in Collecting Duct Epithelia

Hemodynamics and vascular regulation

Role of Microsomal Prostaglandin E Synthase 1 in the Kidney

Pathophysiology of Renal Disease and Progression

Erythropoietin Decreases Renal Fibrosis in Mice with Ureteral Obstruction: Role of Inhibiting TGF-–Induced Epithelial-to-Mesenchymal Transition

Complement C5 Mediates Experimental Tubulointerstitial Fibrosis

Uric Acid Heralds Ischemic Tissue Injury to Mobilize Endothelial Progenitor Cells

Dimethylarginine Dimethylaminohydrolase Prevents Progression of Renal Dysfunction by Inhibiting Loss of Peritubular Capillaries and Tubulointerstitial Fibrosis in a Rat Model of Chronic Kidney Disease